Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study.
Pharmacopsychiatry
; 55(6): 297-303, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35793696
Full text:
1
Database:
MEDLINE
Main subject:
Depressive Disorder, Major
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Pharmacopsychiatry
Year:
2022
Type:
Article
Affiliation country:
Canada